Cyclophosphamide pharmacokinetics and pharmacogenetics in children with B-cell non-Hodgkin's lymphoma-Reference-Cited by-同舟云学术

Cyclophosphamide pharmacokinetics and pharmacogenetics in children with B-cell non-Hodgkin's lymphoma

Published:2016-03 Issue: Volume:55 Page:56-64
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Veal Gareth J.^ORCID,Cole Michael,Chinnaswamy Girish,Sludden Julieann,Jamieson David,Errington Julie,Malik Ghada,Hill Christopher R.,Chamberlain Thomas,Boddy Alan V.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference27 articles.

1. The third intergroup rhabdomyosarcoma study;Crist;J Clin Oncol,1995

2. Highly effective induction therapy for stage 4 neuroblastoma in children over 1 year of age;Kushner;J Clin Oncol,1994

3. Clinical pharmacokinetics of cyclophosphamide;Moore;Clin Pharmacokinet,1991

4. Oxazaphosphorines: new therapeutic strategies for an old class of drugs;Giraud;Expert Opin Drug Metab Toxicol,2010

5. Influence of polymorphisms of drug metabolizing enzymes of cyclophosphamide and 4-hydroxycyclophosphamide;Ekhart;Pharmacogenet Genom,2008

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Shikonin mitigates cyclophosphamide-induced cardiotoxicity in mice: the role of sirtuin-1, NLRP3 inflammasome, autophagy, and apoptosis;Journal of Pharmacy and Pharmacology;2024-09-08

2. Impact of dosing strategy on clinical outcomes of patients with lupus nephritis initially treated with lower-than-recommended-dose cyclophosphamide;Heliyon;2024-09

3. Combining cashew gum with cyclophosphamide in murine melanoma model: A strategy for the reduction of side effects;International Journal of Biological Macromolecules;2024-08

4. Pharmacogenomic associations of cyclophosphamide pharmacokinetic candidate genes with 4hydroxycyclophosphamide formation in children with Cancer;Cancer Chemotherapy and Pharmacology;2024-07-30

5. Cyclophosphamide Pharmacogenomic Variation in Cancer Treatment and Its Effect on Bioactivation and Pharmacokinetics;Advances in Pharmacological and Pharmaceutical Sciences;2024-01